Här hittar du finansiell information om InDex och kan prenumerera på pressmeddelanden och rapporter. Om du har frågor vänligen kontakta vår IR-ansvarige.

2021-03-12 · Efter emissionen: Bengt Julander störst ägare i Index Pharma. Efter forskningsbolaget Index Pharmas företrädesemission intar hälsovårdsinvesteraren Bengt Julander, via bolaget Linc, positionen som största ägare i bolaget med drygt 13 procent av aktierna och rösterna.

jan 2020 Se på video fra tidslinje 21:00 https://www.youtube.com/watch?v=TmjAA_sEHGo Här finns en il/iiä.. 3 Nov 2016 For more information, please visit www.indexpharma.com. Publication. This information is information that InDex Pharmaceuticals Holding AB 14 jan 2021 miljoner kronor. Läkemedelsbolaget Index Pharma har beslutat om en fullt garanterad företrädesemission om cirka 533 miljoner kronor före 24 Oct 2012 For additional information about Kappaproct and InDex Pharmaceuticals please visit www.indexpharma.com. Contact InDex Pharmaceuticals: 23 Apr 2014 1 InDex Pharmaceuticals, Tomtebodavägen 23a, 171 77 Stockholm, Sweden. petra.stein@indexpharma.com.

Latest Updates. IJCTPR-2020: This website uses cookies to ensure you get the best experience on this website. Cookies policy. DeclineAccept. InDex Pharma.

Index Pharma CEO Peter Zerhouni presenting at Pareto Securities' 10th annual Health Care Conference

The index measures the performance of the global pharma, biotech, and life sciences sectors. ETFs Tracking Other Mutual Funds Mutual Fund to ETF Converter Tool We’re sorry, there are no active ETFs associated with this index. InDex Pharmaceuticals Holding AB is a Sweden-based company, which is primarily engaged in the healthcare industry.

2021-04-07 · 7 april 2021 - InDex Pharmaceuticals Holding AB (publ) meddelar idag att ett patent som täcker 19 substanser från bolagets DIMS-plattform beviljats av det europeiska patentverket EPO. InDex har en preklinisk portfölj med fler än 150 DNA-baserade ImmunModulerande Sekvenser (DIMS) varav flera redan är skyddade av godkända substanspatent.

Värdering och villkor InDex är baserat i Stockholm. Bolagets aktier (kortnamn INDEX) handlas på Nasdaq First North Growth Market. Redeye AB med e-postadress certifiedadviser@redeye.se och telefonnummer +46 8 121 576 90 är bolagets Certified Adviser. För mer information, vänligen besök www.indexpharma.com. VIKTIG INFORMATION InDex är baserat i Stockholm.

{{ chapter.name }} www.indexpharma.com. Current instruments. Type. Ticker. ISIN.
Hur mycket skatt betalar man som timanställd

För mer information: Peter Zerhouni, VD Tel: +46 8 508 847 35 E-post: peter.zerhouni@indexpharma.com . Kort om InDex Pharmaceuticals Company profile page for Index Pharmaceuticals Holding AB including stock price, company news, press releases, executives, board members, and contact information See the film below to learn more about this growth market and visit our website (https://www.indexpharma.com/sv/) for more information about our drug candidate cobitolimod: a potential new, safe and effective treatment option for inflammatory gut disease ulcerative colitis.

Your browser is not supported. 16 Apr 2020 E-mail: peter.zerhouni@indexpharma.com For more information, please visit www.indexpharma.com PR InDex Pharma FDA and EMA Type, Public.
Vilken typ av skrivare låter så mycket att man kan göra musik med dess utskrift_

INDEX PHARMA: REDEYE HÖJER BASSCENARIO TILL 23:60 KR (14) STOCKHOLM (Nyhetsbyrån Direkt) Redeye höjer sitt riktvärde i basscenariot för

Market share Dashboard Introduction This case study shows deep dive analytics and insights from the healthcare industry, using IMS data. A big pharmaceutical company wants to analyze the data volume and generate measurable economic value from it. INDEX PHARMA: RÖRELSERESULTAT -15,6 MLN KR 2 KV STOCKHOLM (Nyhetsbyrån Direkt) First North-listade Index Pharma, som fokuserar på immunologiska sjukdomar med stora behov av nya behandlingsalternativ, redovisar ett rörelseresultat om -15, InDex Pharmaceuticals Holding does not show any cl This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

Pizza visby stora torget

E-post: peter.zerhouni@indexpharma.com. Tel: +46 (0) 8 122 038 50. Informationen lämnades genom ovanstående kontaktpersons försorg för

Publication The information was submitted for publication through the agency of the contact person set out above at 13:45 CET on March 12, 2021. STOCKHOLM, March 30, 2021 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the company has entered an agreement for services with global clinical research organization Peter Zerhouni, CEO Phone: +46 8 122 038 50 E-mail: peter.zerhouni@indexpharma.com Publication The information was submitted for publication through the agency of the contact person set out above Get information on the NIFTY PHARMA Spot, Futures and Options. Future contracts, charts, technical analysis, compare performance with other indices/stocks and more. Live Nifty, NSE Nifty, What is S&P Select Industry Indices are designed to measure the performance of narrow GICS® sub-industries. The Index comprises stocks in the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. See all ETFs tracking the MSCI World Pharmaceuticals, Biotechnology and Life Sciences Index, including the cheapest and the most popular among them. Compare their price, performance, expenses, and more.

{{ $select.selected.num + '. ' +$select.selected.name }}. {{ eCtrl.event.layout. chapters.title || 'Select chapter' }}. {{ chapter.num }}. {{ chapter.name }}

InDex Pharmaceuticals Holding AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company is focused in pharmaceuticals development. For more information: Peter Zerhouni, CEO Phone: +46 8 122 038 50 E-mail: peter.zerhouni@indexpharma.com. Publication The information was submitted for publication through the agency of the contact person set out above at 13:45 CET on March 12, 2021.

InDex Pharma. Your browser is not supported.